← Leaderboards
Diana S-L. Chow
Baylor College Of Medicine
$1,578,070
Attributed
$3,303,767
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $783.7K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,457,472 · 4
By mechanism
P20$2,853,635 · 3
R01$2,603,837 · 1
Top collaborators
- Martin M Matzuk8 shared
- Chun Li6 shared
- Peiying Yang5 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Puneet Opal$12,814,603
- Andras A. Heczey$2,725,684
- Aaron Peter Thrift$1,079,701
- Suzanne A Fuqua$14,426,929
- King Li$12,256
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsPrevalenceSuccessFuturePrimary Carcinoma Of The Liver CellsInnovationTechnologyResistanceChemistryGrantResearch PersonnelDrug DevelopmentFundingIncidenceApplications GrantsAntineoplastic AgentsComprehensive Cancer CenterInstitutionAnticancer ResearchEnsureCancer Center Planning GrantAdvisory CommitteesCancer Health DisparityEthnic Group
Grant awards (18)
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy$627,482
R01 · FY2025 · CA
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy$61,165
R01 · FY2025 · CA
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy$596,109
R01 · FY2024 · CA
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy$61,165
R01 · FY2024 · CA
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy$614,932
R01 · FY2023 · CA
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy$642,984
R01 · FY2022 · CA
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$282,524
P20 · FY2021 · CA · contact PI
2/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$256,824
P20 · FY2021 · CA
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$243,536
P20 · FY2021 · CA · contact PI
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$283,076
P20 · FY2020 · CA · contact PI
2/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$256,824
P20 · FY2020 · CA
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$243,812
P20 · FY2020 · CA · contact PI
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$278,782
P20 · FY2019 · CA · contact PI
2/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$250,265
P20 · FY2019 · CA
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$104,673
P20 · FY2019 · CA · contact PI
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$287,404
P20 · FY2018 · CA · contact PI
2/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$258,006
P20 · FY2018 · CA
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education$107,909
P20 · FY2018 · CA · contact PI